StreetAlpha.app
Home › Stocks › IRON

Disc Medicine, Inc. (IRON)

Healthcare
$75.14
▼ −1.27%
LAST CLOSE · NOV 20

Disc Medicine develops experimental drugs for serious blood disorders, based in Watertown, Massachusetts. It last closed at $75.14 on Nov 20, down 1.27% on the day. The next earnings report for IRON is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, IRON reported EPS of -$1.53. Over its last 8 reports the stock moved an average of 2.4% the session after earnings. Over the last 12 months IRON insiders bought $0 of stock on the open market and sold $48.8M, according to SEC Form 4 filings.

AI Auto Pilots
Is IRON in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IRON.

Key Stats

Last 12 months
Results
Net income
−$243.1M
EPS (diluted)
−$6.34
Free cash flow
−$190.0M
Valuation
Market cap
$3.4B
45.5M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$90.0M
At Sep 30
Debt
$59.7M
At Sep 30
Shareholder equity
$604.3M
Shares outstanding
45.5M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$36.0M−$36.0MFY2021FY2022: −$46.8M−$46.8MFY2022FY2023: −$76.4M−$76.4MFY2023FY2024: −$109.4M−$109.4MFY2024FY2025: −$212.2M−$212.2MFY2025

From IRON's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
-$1.53
Quarter ended Sep 2026
Year ago EPS
-$1.77
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.98Dec '24Mar 2025: -$1.02Mar '25Jun 2025: -$1.58Jun '25Sep 2025: -$1.77Sep '25Dec 2025: -$1.62Dec '25Mar 2026: -$1.65Mar '26Jun 2026: -$1.54Jun '26Sep 2026: -$1.53Sep '26Latest -$1.53
Revenue by quarter
Not enough quarters on file yet.
How IRON moved after its last 8 reports
Average move the session after a report ±2.4%
Oct 22, 2026After the close−0.7%
Jul 30, 2026Time not announced+7.5%
May 5, 2026Time not announced−0.1%
Feb 26, 2026Time not announced+1.5%
Jan 12, 2026Time not announced+1.1%
Oct 20, 2025Time not announced−3.1%
Aug 7, 2025Time not announced−3.3%
May 7, 2025Time not announced+2.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on IRONStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on IRON: 0 upgrades, 0 downgrades, 0 initiations
Cantor FitzgeraldReiterated
Nov 22Overweight 
Cantor FitzgeraldReiterated
Nov 21  

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on IRON
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on IRON

Technical Analysis

IRON · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 6% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the 100 day average at $74.72, and the nearest resistance the Pivot at $75.56.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 5.1%/day
Key levels
$99.5052 week high+32.4%
$80.1720 day average+6.7%
$76.59Pivot R1+1.9%
$76.51Swing high (Jul 24)+1.8%
$75.56Pivot+0.6%
$75.14Last close
$74.72100 day average−0.6%
$74.46Swing low (Aug 17)−0.9%
$74.12Pivot S1−1.4%
$71.7150 day average−4.6%
$70.87200 day average−5.7%
$40.0052 week low−46.8%
Indicators
RSI (14)46.81Middle of its rangeNeutral
MACD1.26Below its signal lineBearish
Stochastic11.3Near the bottom of its rangeOversold
ADX (14)27.9Trending up
Williams %R-95.4Oversold below −80, overbought above −20Oversold
CCI (20)-132.0Oversold below −100, overbought above 100Oversold
Rate of change−4.8%Change over 10 sessionsBearish
ATR (14)$3.85Typical daily range, 5.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for IRON

What happened before

See how IRON did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow IRON usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How IRON has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for IRONHow many large options trades hit IRON, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

IRON Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲135 buying vs 83 selling
  • ▲Held by funds +1.0 pts
  • ▲Funds holding +19
  • ▼Superinvestors: 0 added, 2 cut
  • ▼Put/call 0.18 to 1.17
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding237218+8.7%
In funds' top 10770.0%
Held by funds95.8%94.8%+1.0 pts
New / increased43 / 9236 / 75+21.6%
Reduced / sold out59 / 2462 / 22−1.2%
Put/call ratio1.170.18+551.6%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IRON institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

IRON Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$48.8M33 sales · 7 insiders
58% of the selling was under pre-arranged trading plans.
2025-12 sold $21.8M2026-01 sold $581K2026-02 sold $2.5M2026-03 sold $486K2026-04 sold $841K2026-06 sold $5.1M2026-07 sold $2.5M2026-08 sold $3.8M2026-09 sold $6.4M2026-10 sold $3.4M2026-11 sold $1.4MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 10William Jacob SavageChief Medical OfficerSale plan16,035$85.09$1.4M
Oct 21Kevin BittermanDirectorSale plan41,825$80.13$3.4M
Sep 11Kevin BittermanDirectorSale27,136$70.11$1.9M
Sep 4Kevin BittermanDirectorSale plan1,689$79.96$135K
Sep 3Kevin BittermanDirectorSale plan54,496$80.15$4.4M
Aug 25Jonathan Yen-Wen YuCOOSale plan9,096$83.10$756K
Every insider buy and sale for IRON over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See IRON insider trades →

From SEC Form 4 filings by IRON's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IRON is in one of them and how their past IRON trades turned out.

IRON in the AI portfolios
Loading…

IRON News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IRON in an article yet. Here's the latest on the wider market.

IRON in the news

About Disc Medicine

Disc Medicine is a drug developer based in Watertown, Massachusetts, that focuses on treatments for serious blood disorders. Its work centers on the heme and iron pathways that help form red blood cells and carry oxygen. The company is developing bitopertin for porphyrias, DISC-0974 for anemia linked to myelofibrosis and inflammatory bowel disease, and DISC-3405 for polycythemia vera and sickle cell disease. Its product candidates are still in clinical development and are aimed at patients with blood diseases.

Headquarters
Watertown, MA